Skip to main content

Biotricity Inc.

BTCY
Exchange
OTC
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001630113

No open-market purchases or sales by Biotricity Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $5.99K in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Biotricity Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of BTCY: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders115+14
Shares15.0K191.9K+176.9K (+1,179.4%)
Value$47.0K$564.0K+$517.0K (+1,100.0%)

New holders (14)

Institutions that held Biotricity Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to BTCY in Q3 2021
InstitutionSharesValue% of portfolio
HighTower Advisors, LLC56,900$167.0K0.00%
Geode Capital Management, LLC31,571$93.0K0.00%
Magnus Financial Group LLC18,370$54.0K0.01%
Citadel Advisors LLC12,442$37.0K0.00%
Signature Wealth Management Partners, LLC12,000$35.0K0.03%
National Asset Management, Inc.10,925$33.0K0.00%
StoneX Group Inc.10,959$32.0K0.00%
Moors & Cabot, Inc.10,000$29.0K0.00%
Cedar Mountain Advisors, LLC5,000$15.0K0.00%
Advisor Group Holdings, Inc.3,700$10.0K0.00%
Bank of America Corp2,048$6.00K0.00%
Royal Bank of Canada1,300$4.00K0.00%
Wolff Wiese Magana LLC1,000$3.00K0.00%
Morgan Stanley693$2.00K0.00%

Sold out (0)

Institutions that held Biotricity Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

None.